Understanding the Changes in Medicare Part D for 2025
Watch the Recording Below
Originally Presented
Thursday, September 17, 2024
Understanding the Medicare prescription drug provisions in the Inflation Reduction Act is important – whether you are currently enrolled in Medicare, or you may qualify in the future. This presentation includes:
- An overview of the Medicare Part D prescription drug benefit
- Out-of-pocket cap on beneficiary costs ($2,000 in 2025)
- Medicare Prescription Payment Plan which will allow people to spread their drug costs over the calendar year
- Other provisions, including drug price negotiation
- Discussion of measures aimed at keeping premiums down
- Q & A.
Presented by Amy Niles, Chief Mission Officer, PAN Foundation, and David Lipschutz, Co-Director, Center for Medicare Advocacy.
With gratitude, this program is presented in partnership with the PAN Foundation.
Presenter Bios
David Lipschutz, Co-Director, Law & Policy, joined the Center for Medicare Advocacy in June 2010. Based in Washington, DC, David engages in public policy issues surrounding Medicare and related coverage as they impact Medicare beneficiaries. This work includes federal administrative and legislative advocacy, collaboration with other consumer advocates to address systemic issues, and monitoring, analyzing and commenting on current Medicare-related policy developments. He is also a contributing author to the Center’s Medicare Handbook. David earned his B.A. degree from University of California, Santa Cruz in 1993 and his J.D. degree from University of California, Davis in 1999.
Amy Niles is a knowledgeable healthcare executive with a passion for growing sustainable health organizations, advocating for patients, and building strategic partnerships to address public health needs. As PAN’s Chief Mission Officer, she leads the organization’s education initiatives, program development, clinical affairs, and advocacy strategy, while overseeing public policy and advocacy initiatives, external relations, and marketing and communications.
She developed the framework for PAN’s national advocacy platform in 2013 and has been leading the initiative ever since. As a result of her leadership and proactive analysis of the legislative and regulatory environment, external stakeholders and policymakers have come to view PAN as a thought leader and “go-to” resource. She has been quoted in The New York Times, TIME, and HuffPost, and she has authored and co-authored numerous opinion pieces and articles about Medicare reforms and affordability.
Amy believes that no one with a serious illness should have to worry about how to access and afford treatment. She is motivated every day by the knowledge that she is working to fill gaps in the nation’s healthcare system to support vulnerable populations, one person at a time.
She has previously helped lead successful startups and growth initiatives, including the Together Rx Access program. She co-founded, developed, and served as President and CEO of the National Women’s Health Resource Center (NWHRC), which grew into a national clearinghouse for women’s health information under her leadership. Amy has more than thirty years of experience in health nonprofit leadership, including strategy, external relations, and board governance, but her colleagues are most impressed by the way she leads with heart and her dedication to every person PAN serves. Amy also serves on the Board of the Specialty Pharmacy Certification Board, an unincorporated division within the National Association of Specialty Pharmacy (NASP) and is a member of the Center for Value-Based Insurance Design’s Advisory Board.